2010 Stories, most recent news story added Sat Dec 26, 2:33 am ET
WASHINGTON (AP) — Scientists can start using taxpayer dollars to do research with 13 batches of embryonic stem cells and the government says dozens more cell lines should be available soon, opening a new era for the potentially life-saving field.
Like a child awaiting the arrival of Christmas, embryonic stem cells exist in a state of permanent anticipation. They must balance the ability to quickly become more specialized cell types with the cellular chaos that could occur should they act too early (stop shaking those presents, kids!).
PITTSBURGH, Dec. 25 (UPI) -- Umbilical cord tissue could be a source of plentiful stem cells, U.S. researchers said.
THURSDAY, Dec. 24 (HealthDay News) -- Vitamin C is often recommended to help fight the common cold and heal wounds, but the antioxidant might have another benefit: it appears to help adult cells generate embryonic-like stem cells, new research suggests.
( Cell Press ) Famous for its antioxidant properties and role in tissue repair, vitamin C is touted as beneficial for illnesses ranging from the common cold to cancer and perhaps even for slowing the aging process. Now, a study published online on Dec. 24 by Cell Press in the journal Cell Stem Cell uncovers an unexpected new role for this natural compound: facilitating the generation of ...
Soon after the exciting discovery of a method to transform human skin cells into stem cells in 2006 came the frustration of actually trying to make a sufficient amount of these induced pluripotent stem (iPS) cells . The process is so inefficient that scientists typically only get 0.01 percent of a sample of human skin, or fibroblast, cells to form iPS cell colonies after they infect fibroblasts ...
NeoStem, Inc. , which is a leading provider of pre-disease adult stem cell collection, processing and long-term storage services, and holds the exclusive, worldwide license to VSEL⢠technology that uses very small embryonic-like stem cells isolated from peripheral blood, announced today that five posters and two oral presentations at the prestigious American Society of Hematology Annual Meeting ...
Irvine-based California Stem Cell, a manufacturer of human stem cells, said today that it has raised a Series B round of funding. Amount of funding, and the investors, was not disclosed by the company. The firm said the new funding will go to support the advancement of its products toward human clinical trials, plus towards generation and distribution of its tools. California Stem Cell is ...
Tis the time to be amazed: A 38-year-old man has regained vision in his blind eye thanks to a new stem cell therapy. It won't cure all blind people, but it's a giant leap. Here's how it works....
TAMPA, FL--(Marketwire - December 23, 2009) - Stem Cell Therapy International, Inc. ( OTCBB : SCII ) announced that its pre-closing conditions for its merger with Histostem Co. Ltd. ("Histostem") are proceeding on schedule with an expected close of the merger in January 2010. Shareholders have approved changing the Company's name to AmStem Corporation and approved an increase in authorized ...
Steve Cochran figured he'd just strained a muscle, and in a manner of speaking, he was right.The trouble is, the muscle was his heart. And the soreness radiating across his chest following that routine jog in October signaled Cochran was suffering a full-blown heart attack."After it didn't go away," he recalls, "I called 9-1-1."Although the staff at Baptist Memorial Hospital-Memphis quickly ...
MILWAUKEE - By fusing mouse and human cells, scientists at Stanford have uncovered part of the mechanism involved in reprogramming skin cells back to their embryonic origin, and in doing so have
British scientists have used stem cells to restored good vision to eight people who had lost sight in one eye, the Financial Times reports.
Russell Turnbull, now 38, lost almost all the sight in his right eye after trying to break up a fight and being sprayed with ammonia 15 years ago. The result for him was what's known as Limbal Stem Cell Deficiency, which caused him great pain, the need for therapeutic treatment, and economic dependency. Good news for Russell is that he can put all that behind him now, after becoming one of the ...
Pfizer said Sunday that it was buying the rights to a somewhat controversial cell therapy from Athersys , a biotechnology company — a sign of big pharmaceutical companies’ growing interest in stem cells, The New York Times’s Andrew Pollack reported.
New research shows how a crucial step in stem-cell growth and differentiation happens and how a reversal of that step contributes to cancer. It shows that three key proteins first stimulate stem cells to proliferate. Then, as the cells differentiate into their final cell type, these proteins switch function and stop the cells from dividing any more. Because of their central role, the proteins ...
Open slideshowAFP/Getty Images/FileOpen slideshowAFP/Getty Images/File
Open slideshowReuters
Open slideshowAFP/Getty Images/File
Open slideshowReuters